TJ191

TJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.

1522415-97-9

≥ 2 years

>98% (HPLC)

255.38

C13H21NO2S

Research use only, not for human use.

Apoptosis

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1086475-01 0.02 mg (E-Coli)

Ask

MBS1086475-02 0.1 mg (E-Coli)

Ask

MBS1086475-03 0.02 mg (Yeast)

Ask

MBS1086475-04 0.1 mg (Yeast)

Ask

MBS1086475-05 0.02 mg (Baculovirus)

Ask

MBS1086475-06 0.02 mg (Mammalian-Cell)

Ask